Medical Care
Global Stem Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 06, 25
- ID: 291947
- Pages: 166
- Figures: 168
- Views: 8
In 2024, the global market size of Stem Cells was estimated to be worth US$ 3381 million and is forecast to reach approximately US$ 6906 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
Market Driver:
The Stem Cells market is driven by increasing research and development in regenerative medicine and the growing demand for innovative treatments for chronic diseases. Stem cell therapy has shown promising results in treating conditions such as neurodegenerative disorders, cardiovascular diseases, and orthopedic injuries. Additionally, advancements in biotechnology, such as induced pluripotent stem cells (iPSCs) and CRISPR-based gene editing, are expanding the potential applications of stem cells in personalized medicine. Government and private sector investments in stem cell research, along with regulatory approvals for new therapies, are further propelling market growth.
Market Challenge:
Despite its potential, the Stem Cells market faces challenges related to ethical concerns, regulatory complexities, and high costs. The use of embryonic stem cells remains controversial, leading to restrictions in certain regions. Additionally, stem cell therapies require stringent regulatory approvals due to safety concerns, including tumor formation and immune rejection risks. The high cost of stem cell treatments and the complexity of large-scale manufacturing also pose barriers to widespread adoption. Overcoming these challenges requires continued research, improved standardization, and policy support to ensure the safe and ethical development of stem cell therapies.
Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cells.
The Stem Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Global Cord Blood Corporation
Beijing Health-Biotech Group
ABMD
Segment by Type
Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
Segment by Application
Blood Disease
Cancer
Autoimmune Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Stem Cells in global and regional level.
Chapter 3: Detailed analysis of Stem Cells company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cells revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
Market Driver:
The Stem Cells market is driven by increasing research and development in regenerative medicine and the growing demand for innovative treatments for chronic diseases. Stem cell therapy has shown promising results in treating conditions such as neurodegenerative disorders, cardiovascular diseases, and orthopedic injuries. Additionally, advancements in biotechnology, such as induced pluripotent stem cells (iPSCs) and CRISPR-based gene editing, are expanding the potential applications of stem cells in personalized medicine. Government and private sector investments in stem cell research, along with regulatory approvals for new therapies, are further propelling market growth.
Market Challenge:
Despite its potential, the Stem Cells market faces challenges related to ethical concerns, regulatory complexities, and high costs. The use of embryonic stem cells remains controversial, leading to restrictions in certain regions. Additionally, stem cell therapies require stringent regulatory approvals due to safety concerns, including tumor formation and immune rejection risks. The high cost of stem cell treatments and the complexity of large-scale manufacturing also pose barriers to widespread adoption. Overcoming these challenges requires continued research, improved standardization, and policy support to ensure the safe and ethical development of stem cell therapies.
Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cells.
The Stem Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Global Cord Blood Corporation
Beijing Health-Biotech Group
ABMD
Segment by Type
Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
Segment by Application
Blood Disease
Cancer
Autoimmune Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Stem Cells in global and regional level.
Chapter 3: Detailed analysis of Stem Cells company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cells revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Stem Cells Product Introduction
1.2 Market by Type
1.2.1 Global Stem Cells Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Stem Cell Storage
1.2.3 Stem Cell Pharmaceutical and Treatment
1.3 Market by Application
1.3.1 Global Stem Cells Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Blood Disease
1.3.3 Cancer
1.3.4 Autoimmune Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Stem Cells Market Size Estimates and Forecasts
2.2 Stem Cells Market Size by Region: 2024 Versus 2031
2.2.1 Global Stem Cells Revenue by Region: 2020-2025
2.2.2 Global Stem Cells Revenue Forecast by Region (2026-2031)
2.2.3 Global Stem Cells Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Stem Cells Revenue by Type (2020-2031)
3.1.2 Global Stem Cells Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Stem Cells Revenue by Application (2020-2031)
3.2.2 Global Stem Cells Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Stem Cell Storage of Stem Cells Revenue Market Share by Application
3.3.2 Stem Cell Pharmaceutical and Treatment of Stem Cells Revenue Market Share by Application
4 Global Stem Cells by Company
4.1 Global Stem Cells Revenue by Company (2020-2025)
4.2 Global Stem Cells Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Stem Cells Companies around the World: Ranking by Revenue
4.3.2 Global Stem Cells Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Stem Cells Companies Headquarters & Product Type
4.4.1 Global Stem Cells Companies Headquarters
4.4.2 Date of International Companies Enter into Stem Cells Market
4.4.3 Global Stem Cells Companies Product & Service
4.4.4 Stem Cell Storage Revenue Market Share of Stem Cells by Company
4.4.5 Stem Cell Pharmaceutical and Treatment Revenue Market Share of Stem Cells by Company
4.5 Global Stem Cells Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Osiris Therapeutics
5.1.1 Osiris Therapeutics Corporation Information
5.1.2 Osiris Therapeutics Description, Business Overview
5.1.3 Osiris Therapeutics Stem Cells Products Offered
5.1.4 Osiris Therapeutics Stem Cells Revenue and Gross Margin (2020-2025)
5.1.5 Osiris Therapeutics Stem Cells Revenue by Product in 2024
5.1.6 Osiris Therapeutics Stem Cells Revenue by Application in 2024
5.1.7 Osiris Therapeutics Stem Cells Revenue by Geographic Area in 2024
5.1.8 Osiris Therapeutics Recent Developments
5.2 NuVasive
5.2.1 NuVasive Corporation Information
5.2.2 NuVasive Description, Business Overview
5.2.3 NuVasive Stem Cells Products Offered
5.2.4 NuVasive Stem Cells Revenue and Gross Margin (2020-2025)
5.2.5 NuVasive Stem Cells Revenue by Product in 2024
5.2.6 NuVasive Stem Cells Revenue by Application in 2024
5.2.7 NuVasive Stem Cells Revenue by Geographic Area in 2024
5.2.8 NuVasive Recent Developments
5.3 Chiesi Pharmaceuticals
5.3.1 Chiesi Pharmaceuticals Corporation Information
5.3.2 Chiesi Pharmaceuticals Description, Business Overview
5.3.3 Chiesi Pharmaceuticals Stem Cells Products Offered
5.3.4 Chiesi Pharmaceuticals Stem Cells Revenue and Gross Margin (2020-2025)
5.3.5 Chiesi Pharmaceuticals Stem Cells Revenue by Product in 2024
5.3.6 Chiesi Pharmaceuticals Stem Cells Revenue by Application in 2024
5.3.7 Chiesi Pharmaceuticals Stem Cells Revenue by Geographic Area in 2024
5.3.8 Chiesi Pharmaceuticals Recent Developments
5.4 Medi-post
5.4.1 Medi-post Corporation Information
5.4.2 Medi-post Description, Business Overview
5.4.3 Medi-post Stem Cells Products Offered
5.4.4 Medi-post Stem Cells Revenue and Gross Margin (2020-2025)
5.4.5 Medi-post Stem Cells Revenue by Product in 2024
5.4.6 Medi-post Stem Cells Revenue by Application in 2024
5.4.7 Medi-post Stem Cells Revenue by Geographic Area in 2024
5.4.8 Medi-post Recent Developments
5.5 JCR Pharmaceutical
5.5.1 JCR Pharmaceutical Corporation Information
5.5.2 JCR Pharmaceutical Description, Business Overview
5.5.3 JCR Pharmaceutical Stem Cells Products Offered
5.5.4 JCR Pharmaceutical Stem Cells Revenue and Gross Margin (2020-2025)
5.5.5 JCR Pharmaceutical Stem Cells Revenue by Product in 2024
5.5.6 JCR Pharmaceutical Stem Cells Revenue by Application in 2024
5.5.7 JCR Pharmaceutical Stem Cells Revenue by Geographic Area in 2024
5.5.8 JCR Pharmaceutical Recent Developments
5.6 MolMed
5.6.1 MolMed Corporation Information
5.6.2 MolMed Description, Business Overview
5.6.3 MolMed Stem Cells Products Offered
5.6.4 MolMed Stem Cells Revenue and Gross Margin (2020-2025)
5.6.5 MolMed Stem Cells Revenue by Product in 2024
5.6.6 MolMed Stem Cells Revenue by Application in 2024
5.6.7 MolMed Stem Cells Revenue by Geographic Area in 2024
5.6.8 MolMed Recent Developments
5.7 Pharmicell
5.7.1 Pharmicell Corporation Information
5.7.2 Pharmicell Description, Business Overview
5.7.3 Pharmicell Stem Cells Products Offered
5.7.4 Pharmicell Stem Cells Revenue and Gross Margin (2020-2025)
5.7.5 Pharmicell Stem Cells Revenue by Product in 2024
5.7.6 Pharmicell Stem Cells Revenue by Application in 2024
5.7.7 Pharmicell Stem Cells Revenue by Geographic Area in 2024
5.7.8 Pharmicell Recent Developments
5.8 Anterogen
5.8.1 Anterogen Corporation Information
5.8.2 Anterogen Description, Business Overview
5.8.3 Anterogen Stem Cells Products Offered
5.8.4 Anterogen Stem Cells Revenue and Gross Margin (2020-2025)
5.8.5 Anterogen Stem Cells Revenue by Product in 2024
5.8.6 Anterogen Stem Cells Revenue by Application in 2024
5.8.7 Anterogen Stem Cells Revenue by Geographic Area in 2024
5.8.8 Anterogen Recent Developments
5.9 Takeda (TiGenix)
5.9.1 Takeda (TiGenix) Corporation Information
5.9.2 Takeda (TiGenix) Description, Business Overview
5.9.3 Takeda (TiGenix) Stem Cells Products Offered
5.9.4 Takeda (TiGenix) Stem Cells Revenue and Gross Margin (2020-2025)
5.9.5 Takeda (TiGenix) Stem Cells Revenue by Product in 2024
5.9.6 Takeda (TiGenix) Stem Cells Revenue by Application in 2024
5.9.7 Takeda (TiGenix) Stem Cells Revenue by Geographic Area in 2024
5.9.8 Takeda (TiGenix) Recent Developments
5.10 CBR
5.10.1 CBR Corporation Information
5.10.2 CBR Description, Business Overview
5.10.3 CBR Stem Cells Products Offered
5.10.4 CBR Stem Cells Revenue and Gross Margin (2020-2025)
5.10.5 CBR Stem Cells Revenue by Product in 2024
5.10.6 CBR Stem Cells Revenue by Application in 2024
5.10.7 CBR Stem Cells Revenue by Geographic Area in 2024
5.10.8 CBR Recent Developments
5.11 ViaCord
5.11.1 ViaCord Corporation Information
5.11.2 ViaCord Description, Business Overview
5.11.3 ViaCord Stem Cells Products Offered
5.11.4 ViaCord Stem Cells Revenue and Gross Margin (2020-2025)
5.11.5 ViaCord Stem Cells Revenue by Product in 2024
5.11.6 ViaCord Stem Cells Revenue by Application in 2024
5.11.7 ViaCord Stem Cells Revenue by Geographic Area in 2024
5.11.8 ViaCord Recent Developments
5.12 Esperite
5.12.1 Esperite Corporation Information
5.12.2 Esperite Description, Business Overview
5.12.3 Esperite Stem Cells Products Offered
5.12.4 Esperite Stem Cells Revenue and Gross Margin (2020-2025)
5.12.5 Esperite Stem Cells Revenue by Product in 2024
5.12.6 Esperite Stem Cells Revenue by Application in 2024
5.12.7 Esperite Stem Cells Revenue by Geographic Area in 2024
5.12.8 Esperite Recent Developments
5.13 LifeCell
5.13.1 LifeCell Corporation Information
5.13.2 LifeCell Description, Business Overview
5.13.3 LifeCell Stem Cells Products Offered
5.13.4 LifeCell Stem Cells Revenue and Gross Margin (2020-2025)
5.13.5 LifeCell Stem Cells Revenue by Product in 2024
5.13.6 LifeCell Stem Cells Revenue by Application in 2024
5.13.7 LifeCell Stem Cells Revenue by Geographic Area in 2024
5.13.8 LifeCell Recent Developments
5.14 CCBC
5.14.1 CCBC Corporation Information
5.14.2 CCBC Description, Business Overview
5.14.3 CCBC Stem Cells Products Offered
5.14.4 CCBC Stem Cells Revenue and Gross Margin (2020-2025)
5.14.5 CCBC Stem Cells Revenue by Product in 2024
5.14.6 CCBC Stem Cells Revenue by Application in 2024
5.14.7 CCBC Stem Cells Revenue by Geographic Area in 2024
5.14.8 CCBC Recent Developments
5.15 VCANBIO
5.15.1 VCANBIO Corporation Information
5.15.2 VCANBIO Description, Business Overview
5.15.3 VCANBIO Stem Cells Products Offered
5.15.4 VCANBIO Stem Cells Revenue and Gross Margin (2020-2025)
5.15.5 VCANBIO Stem Cells Revenue by Product in 2024
5.15.6 VCANBIO Stem Cells Revenue by Application in 2024
5.15.7 VCANBIO Stem Cells Revenue by Geographic Area in 2024
5.15.8 VCANBIO Recent Developments
5.16 BOYA LIFE
5.16.1 BOYA LIFE Corporation Information
5.16.2 BOYA LIFE Description, Business Overview
5.16.3 BOYA LIFE Stem Cells Products Offered
5.16.4 BOYA LIFE Stem Cells Revenue and Gross Margin (2020-2025)
5.16.5 BOYA LIFE Stem Cells Revenue by Product in 2024
5.16.6 BOYA LIFE Stem Cells Revenue by Application in 2024
5.16.7 BOYA LIFE Stem Cells Revenue by Geographic Area in 2024
5.16.8 BOYA LIFE Recent Developments
5.17 Beike Biotechnology
5.17.1 Beike Biotechnology Corporation Information
5.17.2 Beike Biotechnology Description, Business Overview
5.17.3 Beike Biotechnology Stem Cells Products Offered
5.17.4 Beike Biotechnology Stem Cells Revenue and Gross Margin (2020-2025)
5.17.5 Beike Biotechnology Stem Cells Revenue by Product in 2024
5.17.6 Beike Biotechnology Stem Cells Revenue by Application in 2024
5.17.7 Beike Biotechnology Stem Cells Revenue by Geographic Area in 2024
5.17.8 Beike Biotechnology Recent Developments
5.18 International Medical
5.18.1 International Medical Corporation Information
5.18.2 International Medical Description, Business Overview
5.18.3 International Medical Stem Cells Products Offered
5.18.4 International Medical Stem Cells Revenue and Gross Margin (2020-2025)
5.18.5 International Medical Stem Cells Revenue by Product in 2024
5.18.6 International Medical Stem Cells Revenue by Application in 2024
5.18.7 International Medical Stem Cells Revenue by Geographic Area in 2024
5.18.8 International Medical Recent Developments
5.19 Global Cord Blood Corporation
5.19.1 Global Cord Blood Corporation Corporation Information
5.19.2 Global Cord Blood Corporation Description, Business Overview
5.19.3 Global Cord Blood Corporation Stem Cells Products Offered
5.19.4 Global Cord Blood Corporation Stem Cells Revenue and Gross Margin (2020-2025)
5.19.5 Global Cord Blood Corporation Stem Cells Revenue by Product in 2024
5.19.6 Global Cord Blood Corporation Stem Cells Revenue by Application in 2024
5.19.7 Global Cord Blood Corporation Stem Cells Revenue by Geographic Area in 2024
5.19.8 Global Cord Blood Corporation Recent Developments
5.20 Beijing Health-Biotech Group
5.20.1 Beijing Health-Biotech Group Corporation Information
5.20.2 Beijing Health-Biotech Group Description, Business Overview
5.20.3 Beijing Health-Biotech Group Stem Cells Products Offered
5.20.4 Beijing Health-Biotech Group Stem Cells Revenue and Gross Margin (2020-2025)
5.20.5 Beijing Health-Biotech Group Stem Cells Revenue by Product in 2024
5.20.6 Beijing Health-Biotech Group Stem Cells Revenue by Application in 2024
5.20.7 Beijing Health-Biotech Group Stem Cells Revenue by Geographic Area in 2024
5.20.8 Beijing Health-Biotech Group Recent Developments
5.21 ABMD
5.21.1 ABMD Corporation Information
5.21.2 ABMD Description, Business Overview
5.21.3 ABMD Stem Cells Products Offered
5.21.4 ABMD Stem Cells Revenue and Gross Margin (2020-2025)
5.21.5 ABMD Stem Cells Revenue by Product in 2024
5.21.6 ABMD Stem Cells Revenue by Application in 2024
5.21.7 ABMD Stem Cells Revenue by Geographic Area in 2024
5.21.8 ABMD Recent Developments
6 North America
6.1 North America Stem Cells Market Size YoY Growth 2020-2031
6.2 North America Stem Cells Market Facts & Figures by Country (2020-2031)
6.3 North America Stem Cells Revenue by Type (2020-2025)
6.4 North America Stem Cells Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Stem Cells Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Stem Cells Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Stem Cells Revenue by Type (2020-2025)
7.4 Asia-Pacific Stem Cells Revenue by Application (2020-2025)
8 Europe
8.1 Europe Stem Cells Market Size YoY Growth 2020-2031
8.2 Europe Stem Cells Market Facts & Figures by Country (2020-2031)
8.3 Europe Stem Cells Revenue by Type (2020-2025)
8.4 Europe Stem Cells Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Stem Cells Market Size YoY Growth 2020-2031
9.2 Latin America Stem Cells Market Facts & Figures by Country (2020-2031)
9.3 Latin America Stem Cells Revenue by Type (2020-2025)
9.4 Latin America Stem Cells Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Stem Cells Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Stem Cells Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Stem Cells Revenue by Type (2020-2025)
10.4 Middle East and Africa Stem Cells Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Stem Cells Supply Chain Analysis
11.2 Stem Cells Key Raw Materials and Upstream Suppliers
11.3 Stem Cells Clients Analysis
11.4 Stem Cells Sales Channel and Sales Model Analysis
11.4.1 Stem Cells Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Stem Cells Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Stem Cells Distributors
12 Stem Cells Market Dynamics
12.1 Stem Cells Industry Trends
12.2 Stem Cells Market Drivers
12.3 Stem Cells Market Challenges
12.4 Stem Cells Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Stem Cells Product Introduction
1.2 Market by Type
1.2.1 Global Stem Cells Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Stem Cell Storage
1.2.3 Stem Cell Pharmaceutical and Treatment
1.3 Market by Application
1.3.1 Global Stem Cells Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Blood Disease
1.3.3 Cancer
1.3.4 Autoimmune Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Stem Cells Market Size Estimates and Forecasts
2.2 Stem Cells Market Size by Region: 2024 Versus 2031
2.2.1 Global Stem Cells Revenue by Region: 2020-2025
2.2.2 Global Stem Cells Revenue Forecast by Region (2026-2031)
2.2.3 Global Stem Cells Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Stem Cells Revenue by Type (2020-2031)
3.1.2 Global Stem Cells Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Stem Cells Revenue by Application (2020-2031)
3.2.2 Global Stem Cells Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Stem Cell Storage of Stem Cells Revenue Market Share by Application
3.3.2 Stem Cell Pharmaceutical and Treatment of Stem Cells Revenue Market Share by Application
4 Global Stem Cells by Company
4.1 Global Stem Cells Revenue by Company (2020-2025)
4.2 Global Stem Cells Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Stem Cells Companies around the World: Ranking by Revenue
4.3.2 Global Stem Cells Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Stem Cells Companies Headquarters & Product Type
4.4.1 Global Stem Cells Companies Headquarters
4.4.2 Date of International Companies Enter into Stem Cells Market
4.4.3 Global Stem Cells Companies Product & Service
4.4.4 Stem Cell Storage Revenue Market Share of Stem Cells by Company
4.4.5 Stem Cell Pharmaceutical and Treatment Revenue Market Share of Stem Cells by Company
4.5 Global Stem Cells Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Osiris Therapeutics
5.1.1 Osiris Therapeutics Corporation Information
5.1.2 Osiris Therapeutics Description, Business Overview
5.1.3 Osiris Therapeutics Stem Cells Products Offered
5.1.4 Osiris Therapeutics Stem Cells Revenue and Gross Margin (2020-2025)
5.1.5 Osiris Therapeutics Stem Cells Revenue by Product in 2024
5.1.6 Osiris Therapeutics Stem Cells Revenue by Application in 2024
5.1.7 Osiris Therapeutics Stem Cells Revenue by Geographic Area in 2024
5.1.8 Osiris Therapeutics Recent Developments
5.2 NuVasive
5.2.1 NuVasive Corporation Information
5.2.2 NuVasive Description, Business Overview
5.2.3 NuVasive Stem Cells Products Offered
5.2.4 NuVasive Stem Cells Revenue and Gross Margin (2020-2025)
5.2.5 NuVasive Stem Cells Revenue by Product in 2024
5.2.6 NuVasive Stem Cells Revenue by Application in 2024
5.2.7 NuVasive Stem Cells Revenue by Geographic Area in 2024
5.2.8 NuVasive Recent Developments
5.3 Chiesi Pharmaceuticals
5.3.1 Chiesi Pharmaceuticals Corporation Information
5.3.2 Chiesi Pharmaceuticals Description, Business Overview
5.3.3 Chiesi Pharmaceuticals Stem Cells Products Offered
5.3.4 Chiesi Pharmaceuticals Stem Cells Revenue and Gross Margin (2020-2025)
5.3.5 Chiesi Pharmaceuticals Stem Cells Revenue by Product in 2024
5.3.6 Chiesi Pharmaceuticals Stem Cells Revenue by Application in 2024
5.3.7 Chiesi Pharmaceuticals Stem Cells Revenue by Geographic Area in 2024
5.3.8 Chiesi Pharmaceuticals Recent Developments
5.4 Medi-post
5.4.1 Medi-post Corporation Information
5.4.2 Medi-post Description, Business Overview
5.4.3 Medi-post Stem Cells Products Offered
5.4.4 Medi-post Stem Cells Revenue and Gross Margin (2020-2025)
5.4.5 Medi-post Stem Cells Revenue by Product in 2024
5.4.6 Medi-post Stem Cells Revenue by Application in 2024
5.4.7 Medi-post Stem Cells Revenue by Geographic Area in 2024
5.4.8 Medi-post Recent Developments
5.5 JCR Pharmaceutical
5.5.1 JCR Pharmaceutical Corporation Information
5.5.2 JCR Pharmaceutical Description, Business Overview
5.5.3 JCR Pharmaceutical Stem Cells Products Offered
5.5.4 JCR Pharmaceutical Stem Cells Revenue and Gross Margin (2020-2025)
5.5.5 JCR Pharmaceutical Stem Cells Revenue by Product in 2024
5.5.6 JCR Pharmaceutical Stem Cells Revenue by Application in 2024
5.5.7 JCR Pharmaceutical Stem Cells Revenue by Geographic Area in 2024
5.5.8 JCR Pharmaceutical Recent Developments
5.6 MolMed
5.6.1 MolMed Corporation Information
5.6.2 MolMed Description, Business Overview
5.6.3 MolMed Stem Cells Products Offered
5.6.4 MolMed Stem Cells Revenue and Gross Margin (2020-2025)
5.6.5 MolMed Stem Cells Revenue by Product in 2024
5.6.6 MolMed Stem Cells Revenue by Application in 2024
5.6.7 MolMed Stem Cells Revenue by Geographic Area in 2024
5.6.8 MolMed Recent Developments
5.7 Pharmicell
5.7.1 Pharmicell Corporation Information
5.7.2 Pharmicell Description, Business Overview
5.7.3 Pharmicell Stem Cells Products Offered
5.7.4 Pharmicell Stem Cells Revenue and Gross Margin (2020-2025)
5.7.5 Pharmicell Stem Cells Revenue by Product in 2024
5.7.6 Pharmicell Stem Cells Revenue by Application in 2024
5.7.7 Pharmicell Stem Cells Revenue by Geographic Area in 2024
5.7.8 Pharmicell Recent Developments
5.8 Anterogen
5.8.1 Anterogen Corporation Information
5.8.2 Anterogen Description, Business Overview
5.8.3 Anterogen Stem Cells Products Offered
5.8.4 Anterogen Stem Cells Revenue and Gross Margin (2020-2025)
5.8.5 Anterogen Stem Cells Revenue by Product in 2024
5.8.6 Anterogen Stem Cells Revenue by Application in 2024
5.8.7 Anterogen Stem Cells Revenue by Geographic Area in 2024
5.8.8 Anterogen Recent Developments
5.9 Takeda (TiGenix)
5.9.1 Takeda (TiGenix) Corporation Information
5.9.2 Takeda (TiGenix) Description, Business Overview
5.9.3 Takeda (TiGenix) Stem Cells Products Offered
5.9.4 Takeda (TiGenix) Stem Cells Revenue and Gross Margin (2020-2025)
5.9.5 Takeda (TiGenix) Stem Cells Revenue by Product in 2024
5.9.6 Takeda (TiGenix) Stem Cells Revenue by Application in 2024
5.9.7 Takeda (TiGenix) Stem Cells Revenue by Geographic Area in 2024
5.9.8 Takeda (TiGenix) Recent Developments
5.10 CBR
5.10.1 CBR Corporation Information
5.10.2 CBR Description, Business Overview
5.10.3 CBR Stem Cells Products Offered
5.10.4 CBR Stem Cells Revenue and Gross Margin (2020-2025)
5.10.5 CBR Stem Cells Revenue by Product in 2024
5.10.6 CBR Stem Cells Revenue by Application in 2024
5.10.7 CBR Stem Cells Revenue by Geographic Area in 2024
5.10.8 CBR Recent Developments
5.11 ViaCord
5.11.1 ViaCord Corporation Information
5.11.2 ViaCord Description, Business Overview
5.11.3 ViaCord Stem Cells Products Offered
5.11.4 ViaCord Stem Cells Revenue and Gross Margin (2020-2025)
5.11.5 ViaCord Stem Cells Revenue by Product in 2024
5.11.6 ViaCord Stem Cells Revenue by Application in 2024
5.11.7 ViaCord Stem Cells Revenue by Geographic Area in 2024
5.11.8 ViaCord Recent Developments
5.12 Esperite
5.12.1 Esperite Corporation Information
5.12.2 Esperite Description, Business Overview
5.12.3 Esperite Stem Cells Products Offered
5.12.4 Esperite Stem Cells Revenue and Gross Margin (2020-2025)
5.12.5 Esperite Stem Cells Revenue by Product in 2024
5.12.6 Esperite Stem Cells Revenue by Application in 2024
5.12.7 Esperite Stem Cells Revenue by Geographic Area in 2024
5.12.8 Esperite Recent Developments
5.13 LifeCell
5.13.1 LifeCell Corporation Information
5.13.2 LifeCell Description, Business Overview
5.13.3 LifeCell Stem Cells Products Offered
5.13.4 LifeCell Stem Cells Revenue and Gross Margin (2020-2025)
5.13.5 LifeCell Stem Cells Revenue by Product in 2024
5.13.6 LifeCell Stem Cells Revenue by Application in 2024
5.13.7 LifeCell Stem Cells Revenue by Geographic Area in 2024
5.13.8 LifeCell Recent Developments
5.14 CCBC
5.14.1 CCBC Corporation Information
5.14.2 CCBC Description, Business Overview
5.14.3 CCBC Stem Cells Products Offered
5.14.4 CCBC Stem Cells Revenue and Gross Margin (2020-2025)
5.14.5 CCBC Stem Cells Revenue by Product in 2024
5.14.6 CCBC Stem Cells Revenue by Application in 2024
5.14.7 CCBC Stem Cells Revenue by Geographic Area in 2024
5.14.8 CCBC Recent Developments
5.15 VCANBIO
5.15.1 VCANBIO Corporation Information
5.15.2 VCANBIO Description, Business Overview
5.15.3 VCANBIO Stem Cells Products Offered
5.15.4 VCANBIO Stem Cells Revenue and Gross Margin (2020-2025)
5.15.5 VCANBIO Stem Cells Revenue by Product in 2024
5.15.6 VCANBIO Stem Cells Revenue by Application in 2024
5.15.7 VCANBIO Stem Cells Revenue by Geographic Area in 2024
5.15.8 VCANBIO Recent Developments
5.16 BOYA LIFE
5.16.1 BOYA LIFE Corporation Information
5.16.2 BOYA LIFE Description, Business Overview
5.16.3 BOYA LIFE Stem Cells Products Offered
5.16.4 BOYA LIFE Stem Cells Revenue and Gross Margin (2020-2025)
5.16.5 BOYA LIFE Stem Cells Revenue by Product in 2024
5.16.6 BOYA LIFE Stem Cells Revenue by Application in 2024
5.16.7 BOYA LIFE Stem Cells Revenue by Geographic Area in 2024
5.16.8 BOYA LIFE Recent Developments
5.17 Beike Biotechnology
5.17.1 Beike Biotechnology Corporation Information
5.17.2 Beike Biotechnology Description, Business Overview
5.17.3 Beike Biotechnology Stem Cells Products Offered
5.17.4 Beike Biotechnology Stem Cells Revenue and Gross Margin (2020-2025)
5.17.5 Beike Biotechnology Stem Cells Revenue by Product in 2024
5.17.6 Beike Biotechnology Stem Cells Revenue by Application in 2024
5.17.7 Beike Biotechnology Stem Cells Revenue by Geographic Area in 2024
5.17.8 Beike Biotechnology Recent Developments
5.18 International Medical
5.18.1 International Medical Corporation Information
5.18.2 International Medical Description, Business Overview
5.18.3 International Medical Stem Cells Products Offered
5.18.4 International Medical Stem Cells Revenue and Gross Margin (2020-2025)
5.18.5 International Medical Stem Cells Revenue by Product in 2024
5.18.6 International Medical Stem Cells Revenue by Application in 2024
5.18.7 International Medical Stem Cells Revenue by Geographic Area in 2024
5.18.8 International Medical Recent Developments
5.19 Global Cord Blood Corporation
5.19.1 Global Cord Blood Corporation Corporation Information
5.19.2 Global Cord Blood Corporation Description, Business Overview
5.19.3 Global Cord Blood Corporation Stem Cells Products Offered
5.19.4 Global Cord Blood Corporation Stem Cells Revenue and Gross Margin (2020-2025)
5.19.5 Global Cord Blood Corporation Stem Cells Revenue by Product in 2024
5.19.6 Global Cord Blood Corporation Stem Cells Revenue by Application in 2024
5.19.7 Global Cord Blood Corporation Stem Cells Revenue by Geographic Area in 2024
5.19.8 Global Cord Blood Corporation Recent Developments
5.20 Beijing Health-Biotech Group
5.20.1 Beijing Health-Biotech Group Corporation Information
5.20.2 Beijing Health-Biotech Group Description, Business Overview
5.20.3 Beijing Health-Biotech Group Stem Cells Products Offered
5.20.4 Beijing Health-Biotech Group Stem Cells Revenue and Gross Margin (2020-2025)
5.20.5 Beijing Health-Biotech Group Stem Cells Revenue by Product in 2024
5.20.6 Beijing Health-Biotech Group Stem Cells Revenue by Application in 2024
5.20.7 Beijing Health-Biotech Group Stem Cells Revenue by Geographic Area in 2024
5.20.8 Beijing Health-Biotech Group Recent Developments
5.21 ABMD
5.21.1 ABMD Corporation Information
5.21.2 ABMD Description, Business Overview
5.21.3 ABMD Stem Cells Products Offered
5.21.4 ABMD Stem Cells Revenue and Gross Margin (2020-2025)
5.21.5 ABMD Stem Cells Revenue by Product in 2024
5.21.6 ABMD Stem Cells Revenue by Application in 2024
5.21.7 ABMD Stem Cells Revenue by Geographic Area in 2024
5.21.8 ABMD Recent Developments
6 North America
6.1 North America Stem Cells Market Size YoY Growth 2020-2031
6.2 North America Stem Cells Market Facts & Figures by Country (2020-2031)
6.3 North America Stem Cells Revenue by Type (2020-2025)
6.4 North America Stem Cells Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Stem Cells Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Stem Cells Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Stem Cells Revenue by Type (2020-2025)
7.4 Asia-Pacific Stem Cells Revenue by Application (2020-2025)
8 Europe
8.1 Europe Stem Cells Market Size YoY Growth 2020-2031
8.2 Europe Stem Cells Market Facts & Figures by Country (2020-2031)
8.3 Europe Stem Cells Revenue by Type (2020-2025)
8.4 Europe Stem Cells Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Stem Cells Market Size YoY Growth 2020-2031
9.2 Latin America Stem Cells Market Facts & Figures by Country (2020-2031)
9.3 Latin America Stem Cells Revenue by Type (2020-2025)
9.4 Latin America Stem Cells Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Stem Cells Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Stem Cells Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Stem Cells Revenue by Type (2020-2025)
10.4 Middle East and Africa Stem Cells Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Stem Cells Supply Chain Analysis
11.2 Stem Cells Key Raw Materials and Upstream Suppliers
11.3 Stem Cells Clients Analysis
11.4 Stem Cells Sales Channel and Sales Model Analysis
11.4.1 Stem Cells Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Stem Cells Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Stem Cells Distributors
12 Stem Cells Market Dynamics
12.1 Stem Cells Industry Trends
12.2 Stem Cells Market Drivers
12.3 Stem Cells Market Challenges
12.4 Stem Cells Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Stem Cells Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Stem Cells Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Stem Cells Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Stem Cells Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Stem Cells Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Stem Cells Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Stem Cells Revenue by Company (2020-2025) & (US$ Million)
Table 11. Stem Cells Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Stem Cells Players by Revenue (US$ Million) in 2024
Table 13. Global Stem Cells Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cells as of 2024)
Table 15. Global Stem Cells Companies Headquarters
Table 16. Date of International Companies Enter into Stem Cells Market
Table 17. Global Stem Cells Companies Product & Service
Table 18. Global Stem Cells Mergers & Acquisitions, Expansion Plans
Table 19. Osiris Therapeutics Corporation Information
Table 20. Osiris Therapeutics Description and Business Overview
Table 21. Osiris Therapeutics Stem Cells Product
Table 22. Osiris Therapeutics Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Osiris Therapeutics Revenue Proportion of Stem Cells by Product in 2024
Table 24. Osiris Therapeutics Revenue Proportion of Stem Cells by Application in 2024
Table 25. Osiris Therapeutics Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 26. Osiris Therapeutics Recent Developments
Table 27. NuVasive Corporation Information
Table 28. NuVasive Description and Business Overview
Table 29. NuVasive Stem Cells Product
Table 30. NuVasive Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. NuVasive Revenue Proportion of Stem Cells by Product in 2024
Table 32. NuVasive Revenue Proportion of Stem Cells by Application in 2024
Table 33. NuVasive Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 34. NuVasive Recent Developments
Table 35. Chiesi Pharmaceuticals Corporation Information
Table 36. Chiesi Pharmaceuticals Description and Business Overview
Table 37. Chiesi Pharmaceuticals Stem Cells Product
Table 38. Chiesi Pharmaceuticals Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Chiesi Pharmaceuticals Revenue Proportion of Stem Cells by Product in 2024
Table 40. Chiesi Pharmaceuticals Revenue Proportion of Stem Cells by Application in 2024
Table 41. Chiesi Pharmaceuticals Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 42. Chiesi Pharmaceuticals Recent Developments
Table 43. Medi-post Corporation Information
Table 44. Medi-post Description and Business Overview
Table 45. Medi-post Stem Cells Product
Table 46. Medi-post Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Medi-post Revenue Proportion of Stem Cells by Product in 2024
Table 48. Medi-post Revenue Proportion of Stem Cells by Application in 2024
Table 49. Medi-post Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 50. Medi-post Recent Developments
Table 51. JCR Pharmaceutical Corporation Information
Table 52. JCR Pharmaceutical Description and Business Overview
Table 53. JCR Pharmaceutical Stem Cells Product
Table 54. JCR Pharmaceutical Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. JCR Pharmaceutical Revenue Proportion of Stem Cells by Product in 2024
Table 56. JCR Pharmaceutical Revenue Proportion of Stem Cells by Application in 2024
Table 57. JCR Pharmaceutical Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 58. JCR Pharmaceutical Recent Developments
Table 59. MolMed Corporation Information
Table 60. MolMed Description and Business Overview
Table 61. MolMed Stem Cells Product
Table 62. MolMed Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. MolMed Revenue Proportion of Stem Cells by Product in 2024
Table 64. MolMed Revenue Proportion of Stem Cells by Application in 2024
Table 65. MolMed Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 66. MolMed Recent Developments
Table 67. Pharmicell Corporation Information
Table 68. Pharmicell Description and Business Overview
Table 69. Pharmicell Stem Cells Product
Table 70. Pharmicell Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Pharmicell Revenue Proportion of Stem Cells by Product in 2024
Table 72. Pharmicell Revenue Proportion of Stem Cells by Application in 2024
Table 73. Pharmicell Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 74. Pharmicell Recent Developments
Table 75. Anterogen Corporation Information
Table 76. Anterogen Description and Business Overview
Table 77. Anterogen Stem Cells Product
Table 78. Anterogen Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Anterogen Revenue Proportion of Stem Cells by Product in 2024
Table 80. Anterogen Revenue Proportion of Stem Cells by Application in 2024
Table 81. Anterogen Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 82. Anterogen Recent Developments
Table 83. Takeda (TiGenix) Corporation Information
Table 84. Takeda (TiGenix) Description and Business Overview
Table 85. Takeda (TiGenix) Stem Cells Product
Table 86. Takeda (TiGenix) Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Takeda (TiGenix) Revenue Proportion of Stem Cells by Product in 2024
Table 88. Takeda (TiGenix) Revenue Proportion of Stem Cells by Application in 2024
Table 89. Takeda (TiGenix) Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 90. Takeda (TiGenix) Recent Developments
Table 91. CBR Corporation Information
Table 92. CBR Description and Business Overview
Table 93. CBR Stem Cells Product
Table 94. CBR Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. CBR Revenue Proportion of Stem Cells by Product in 2024
Table 96. CBR Revenue Proportion of Stem Cells by Application in 2024
Table 97. CBR Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 98. CBR Recent Developments
Table 99. ViaCord Corporation Information
Table 100. ViaCord Description and Business Overview
Table 101. ViaCord Stem Cells Product
Table 102. ViaCord Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. ViaCord Revenue Proportion of Stem Cells by Product in 2024
Table 104. ViaCord Revenue Proportion of Stem Cells by Application in 2024
Table 105. ViaCord Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 106. ViaCord Recent Developments
Table 107. Esperite Corporation Information
Table 108. Esperite Description and Business Overview
Table 109. Esperite Stem Cells Product
Table 110. Esperite Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Esperite Revenue Proportion of Stem Cells by Product in 2024
Table 112. Esperite Revenue Proportion of Stem Cells by Application in 2024
Table 113. Esperite Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 114. Esperite Recent Developments
Table 115. LifeCell Corporation Information
Table 116. LifeCell Description and Business Overview
Table 117. LifeCell Stem Cells Product
Table 118. LifeCell Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. LifeCell Revenue Proportion of Stem Cells by Product in 2024
Table 120. LifeCell Revenue Proportion of Stem Cells by Application in 2024
Table 121. LifeCell Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 122. LifeCell Recent Developments
Table 123. CCBC Corporation Information
Table 124. CCBC Description and Business Overview
Table 125. CCBC Stem Cells Product
Table 126. CCBC Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. CCBC Revenue Proportion of Stem Cells by Product in 2024
Table 128. CCBC Revenue Proportion of Stem Cells by Application in 2024
Table 129. CCBC Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 130. CCBC Recent Developments
Table 131. VCANBIO Corporation Information
Table 132. VCANBIO Description and Business Overview
Table 133. VCANBIO Stem Cells Product
Table 134. VCANBIO Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. VCANBIO Revenue Proportion of Stem Cells by Product in 2024
Table 136. VCANBIO Revenue Proportion of Stem Cells by Application in 2024
Table 137. VCANBIO Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 138. VCANBIO Recent Developments
Table 139. BOYA LIFE Corporation Information
Table 140. BOYA LIFE Description and Business Overview
Table 141. BOYA LIFE Stem Cells Product
Table 142. BOYA LIFE Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. BOYA LIFE Revenue Proportion of Stem Cells by Product in 2024
Table 144. BOYA LIFE Revenue Proportion of Stem Cells by Application in 2024
Table 145. BOYA LIFE Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 146. BOYA LIFE Recent Developments
Table 147. Beike Biotechnology Corporation Information
Table 148. Beike Biotechnology Description and Business Overview
Table 149. Beike Biotechnology Stem Cells Product
Table 150. Beike Biotechnology Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Beike Biotechnology Revenue Proportion of Stem Cells by Product in 2024
Table 152. Beike Biotechnology Revenue Proportion of Stem Cells by Application in 2024
Table 153. Beike Biotechnology Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 154. Beike Biotechnology Recent Developments
Table 155. International Medical Corporation Information
Table 156. International Medical Description and Business Overview
Table 157. International Medical Stem Cells Product
Table 158. International Medical Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. International Medical Revenue Proportion of Stem Cells by Product in 2024
Table 160. International Medical Revenue Proportion of Stem Cells by Application in 2024
Table 161. International Medical Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 162. International Medical Recent Developments
Table 163. Global Cord Blood Corporation Corporation Information
Table 164. Global Cord Blood Corporation Description and Business Overview
Table 165. Global Cord Blood Corporation Stem Cells Product
Table 166. Global Cord Blood Corporation Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. Global Cord Blood Corporation Revenue Proportion of Stem Cells by Product in 2024
Table 168. Global Cord Blood Corporation Revenue Proportion of Stem Cells by Application in 2024
Table 169. Global Cord Blood Corporation Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 170. Global Cord Blood Corporation Recent Developments
Table 171. Beijing Health-Biotech Group Corporation Information
Table 172. Beijing Health-Biotech Group Description and Business Overview
Table 173. Beijing Health-Biotech Group Stem Cells Product
Table 174. Beijing Health-Biotech Group Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 175. Beijing Health-Biotech Group Revenue Proportion of Stem Cells by Product in 2024
Table 176. Beijing Health-Biotech Group Revenue Proportion of Stem Cells by Application in 2024
Table 177. Beijing Health-Biotech Group Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 178. Beijing Health-Biotech Group Recent Developments
Table 179. ABMD Corporation Information
Table 180. ABMD Description and Business Overview
Table 181. ABMD Stem Cells Product
Table 182. ABMD Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. ABMD Revenue Proportion of Stem Cells by Product in 2024
Table 184. ABMD Revenue Proportion of Stem Cells by Application in 2024
Table 185. ABMD Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 186. ABMD Recent Developments
Table 187. North America Stem Cells Revenue by Country (2020-2025) & (US$ Million)
Table 188. North America Stem Cells Revenue by Country (2026-2031) & (US$ Million)
Table 189. North America Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 190. North America Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 191. Asia-Pacific Stem Cells Revenue by Region (2020-2025) & (US$ Million)
Table 192. Asia-Pacific Stem Cells Revenue by Region (2026-2031) & (US$ Million)
Table 193. Asia-Pacific Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 194. Asia-Pacific Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 195. Europe Stem Cells Revenue by Country (2020-2025) & (US$ Million)
Table 196. Europe Stem Cells Revenue by Country (2026-2031) & (US$ Million)
Table 197. Europe Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 198. Europe Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 199. Latin America Stem Cells Revenue by Country (2020-2025) & (US$ Million)
Table 200. Latin America Stem Cells Revenue by Country (2026-2031) & (US$ Million)
Table 201. Latin America Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 202. Latin America Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 203. Middle East and Africa Stem Cells Revenue by Country (2020-2025) & (US$ Million)
Table 204. Middle East and Africa Stem Cells Revenue by Country (2026-2031) & (US$ Million)
Table 205. Middle East and Africa Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 206. Middle East and Africa Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 207. Stem Cells Key Raw Materials, Industry Status and Trend
Table 208. Stem Cells Key Raw Materials and Upstream Suppliers
Table 209. Stem Cells Clients Status and Trend
Table 210. Stem Cells Typical Clients
Table 211. Stem Cells Distributors
Table 212. Stem Cells Market Trends
Table 213. Stem Cells Market Drivers
Table 214. Stem Cells Market Challenges
Table 215. Stem Cells Market Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Stem Cells Product Picture
Figure 2. Global Stem Cells Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Stem Cells Revenue Market Share by Type in 2024 & 2031
Figure 4. Stem Cell Storage Product Picture
Figure 5. Stem Cell Pharmaceutical and Treatment Product Picture
Figure 6. Global Stem Cells Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Stem Cells Revenue Market Share by Application in 2024 & 2031
Figure 8. Blood Disease
Figure 9. Cancer
Figure 10. Autoimmune Disease
Figure 11. Others
Figure 12. Stem Cells Report Years Considered
Figure 13. Global Stem Cells Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Stem Cells Market Size (2020-2031) & (US$ Million)
Figure 15. Global Stem Cells Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Stem Cells Revenue Market Share by Region (2020-2031)
Figure 17. Global Stem Cells Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Stem Cells Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Stem Cell Storage of Stem Cells Revenue Market Share by Application, 2024 VS 2031
Figure 20. Stem Cell Pharmaceutical and Treatment of Stem Cells Revenue Market Share by Application, 2024 VS 2031
Figure 21. Stem Cells Revenue Share by Company (2024)
Figure 22. Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Stem Cell Storage Revenue Proportion by Company in 2024
Figure 24. Stem Cell Pharmaceutical and Treatment Revenue Proportion by Company in 2024
Figure 25. North America Stem Cells Revenue 2020-2031 (US$ Million)
Figure 26. North America Stem Cells Revenue Market Share by Type (2020-2025)
Figure 27. North America Stem Cells Revenue Market Share by Application (2020-2025)
Figure 28. Asia-Pacific Stem Cells Revenue 2020-2031 (US$ Million)
Figure 29. Asia-Pacific Stem Cells Revenue Market Share by Region (2020-2031)
Figure 30. Asia-Pacific Stem Cells Revenue Market Share by Type (2020-2025)
Figure 31. Asia-Pacific Stem Cells Revenue Market Share by Application (2020-2025)
Figure 32. Europe Stem Cells Revenue Growth Rate 2020-2031 (US$ Million)
Figure 33. Europe Stem Cells Revenue Market Share by Country (2020-2031)
Figure 34. Europe Stem Cells Revenue Market Share by Type (2020-2025)
Figure 35. Europe Stem Cells Revenue Market Share by Application (2020-2025)
Figure 36. Latin America Stem Cells Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Latin America Stem Cells Revenue Market Share by Country (2020-2031)
Figure 38. Latin America Stem Cells Revenue Market Share by Type (2020-2025)
Figure 39. Latin America Stem Cells Revenue Market Share by Application (2020-2025)
Figure 40. Middle East and Africa Stem Cells Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Middle East and Africa Stem Cells Revenue Market Share by Country (2020-2031)
Figure 42. Middle East and Africa Stem Cells Revenue Market Share by Type (2020-2025)
Figure 43. Middle East and Africa Stem Cells Revenue Market Share by Application (2020-2025)
Figure 44. Stem Cells Supply Chain (Upstream and Downstream Market)
Figure 45. Global Production Market Share of Stem Cells Raw Materials by Region in 2024
Figure 46. Stem Cells Distribution Channels
Figure 47. Global Stem Cells Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 48. Global Stem Cells Percentage 2020-2031: Online Sales VS Offline Sales
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Table 1. Global Stem Cells Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Stem Cells Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Stem Cells Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Stem Cells Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Stem Cells Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Stem Cells Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Stem Cells Revenue by Company (2020-2025) & (US$ Million)
Table 11. Stem Cells Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Stem Cells Players by Revenue (US$ Million) in 2024
Table 13. Global Stem Cells Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cells as of 2024)
Table 15. Global Stem Cells Companies Headquarters
Table 16. Date of International Companies Enter into Stem Cells Market
Table 17. Global Stem Cells Companies Product & Service
Table 18. Global Stem Cells Mergers & Acquisitions, Expansion Plans
Table 19. Osiris Therapeutics Corporation Information
Table 20. Osiris Therapeutics Description and Business Overview
Table 21. Osiris Therapeutics Stem Cells Product
Table 22. Osiris Therapeutics Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Osiris Therapeutics Revenue Proportion of Stem Cells by Product in 2024
Table 24. Osiris Therapeutics Revenue Proportion of Stem Cells by Application in 2024
Table 25. Osiris Therapeutics Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 26. Osiris Therapeutics Recent Developments
Table 27. NuVasive Corporation Information
Table 28. NuVasive Description and Business Overview
Table 29. NuVasive Stem Cells Product
Table 30. NuVasive Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. NuVasive Revenue Proportion of Stem Cells by Product in 2024
Table 32. NuVasive Revenue Proportion of Stem Cells by Application in 2024
Table 33. NuVasive Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 34. NuVasive Recent Developments
Table 35. Chiesi Pharmaceuticals Corporation Information
Table 36. Chiesi Pharmaceuticals Description and Business Overview
Table 37. Chiesi Pharmaceuticals Stem Cells Product
Table 38. Chiesi Pharmaceuticals Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Chiesi Pharmaceuticals Revenue Proportion of Stem Cells by Product in 2024
Table 40. Chiesi Pharmaceuticals Revenue Proportion of Stem Cells by Application in 2024
Table 41. Chiesi Pharmaceuticals Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 42. Chiesi Pharmaceuticals Recent Developments
Table 43. Medi-post Corporation Information
Table 44. Medi-post Description and Business Overview
Table 45. Medi-post Stem Cells Product
Table 46. Medi-post Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Medi-post Revenue Proportion of Stem Cells by Product in 2024
Table 48. Medi-post Revenue Proportion of Stem Cells by Application in 2024
Table 49. Medi-post Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 50. Medi-post Recent Developments
Table 51. JCR Pharmaceutical Corporation Information
Table 52. JCR Pharmaceutical Description and Business Overview
Table 53. JCR Pharmaceutical Stem Cells Product
Table 54. JCR Pharmaceutical Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. JCR Pharmaceutical Revenue Proportion of Stem Cells by Product in 2024
Table 56. JCR Pharmaceutical Revenue Proportion of Stem Cells by Application in 2024
Table 57. JCR Pharmaceutical Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 58. JCR Pharmaceutical Recent Developments
Table 59. MolMed Corporation Information
Table 60. MolMed Description and Business Overview
Table 61. MolMed Stem Cells Product
Table 62. MolMed Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. MolMed Revenue Proportion of Stem Cells by Product in 2024
Table 64. MolMed Revenue Proportion of Stem Cells by Application in 2024
Table 65. MolMed Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 66. MolMed Recent Developments
Table 67. Pharmicell Corporation Information
Table 68. Pharmicell Description and Business Overview
Table 69. Pharmicell Stem Cells Product
Table 70. Pharmicell Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Pharmicell Revenue Proportion of Stem Cells by Product in 2024
Table 72. Pharmicell Revenue Proportion of Stem Cells by Application in 2024
Table 73. Pharmicell Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 74. Pharmicell Recent Developments
Table 75. Anterogen Corporation Information
Table 76. Anterogen Description and Business Overview
Table 77. Anterogen Stem Cells Product
Table 78. Anterogen Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Anterogen Revenue Proportion of Stem Cells by Product in 2024
Table 80. Anterogen Revenue Proportion of Stem Cells by Application in 2024
Table 81. Anterogen Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 82. Anterogen Recent Developments
Table 83. Takeda (TiGenix) Corporation Information
Table 84. Takeda (TiGenix) Description and Business Overview
Table 85. Takeda (TiGenix) Stem Cells Product
Table 86. Takeda (TiGenix) Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Takeda (TiGenix) Revenue Proportion of Stem Cells by Product in 2024
Table 88. Takeda (TiGenix) Revenue Proportion of Stem Cells by Application in 2024
Table 89. Takeda (TiGenix) Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 90. Takeda (TiGenix) Recent Developments
Table 91. CBR Corporation Information
Table 92. CBR Description and Business Overview
Table 93. CBR Stem Cells Product
Table 94. CBR Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. CBR Revenue Proportion of Stem Cells by Product in 2024
Table 96. CBR Revenue Proportion of Stem Cells by Application in 2024
Table 97. CBR Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 98. CBR Recent Developments
Table 99. ViaCord Corporation Information
Table 100. ViaCord Description and Business Overview
Table 101. ViaCord Stem Cells Product
Table 102. ViaCord Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. ViaCord Revenue Proportion of Stem Cells by Product in 2024
Table 104. ViaCord Revenue Proportion of Stem Cells by Application in 2024
Table 105. ViaCord Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 106. ViaCord Recent Developments
Table 107. Esperite Corporation Information
Table 108. Esperite Description and Business Overview
Table 109. Esperite Stem Cells Product
Table 110. Esperite Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Esperite Revenue Proportion of Stem Cells by Product in 2024
Table 112. Esperite Revenue Proportion of Stem Cells by Application in 2024
Table 113. Esperite Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 114. Esperite Recent Developments
Table 115. LifeCell Corporation Information
Table 116. LifeCell Description and Business Overview
Table 117. LifeCell Stem Cells Product
Table 118. LifeCell Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. LifeCell Revenue Proportion of Stem Cells by Product in 2024
Table 120. LifeCell Revenue Proportion of Stem Cells by Application in 2024
Table 121. LifeCell Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 122. LifeCell Recent Developments
Table 123. CCBC Corporation Information
Table 124. CCBC Description and Business Overview
Table 125. CCBC Stem Cells Product
Table 126. CCBC Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. CCBC Revenue Proportion of Stem Cells by Product in 2024
Table 128. CCBC Revenue Proportion of Stem Cells by Application in 2024
Table 129. CCBC Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 130. CCBC Recent Developments
Table 131. VCANBIO Corporation Information
Table 132. VCANBIO Description and Business Overview
Table 133. VCANBIO Stem Cells Product
Table 134. VCANBIO Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. VCANBIO Revenue Proportion of Stem Cells by Product in 2024
Table 136. VCANBIO Revenue Proportion of Stem Cells by Application in 2024
Table 137. VCANBIO Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 138. VCANBIO Recent Developments
Table 139. BOYA LIFE Corporation Information
Table 140. BOYA LIFE Description and Business Overview
Table 141. BOYA LIFE Stem Cells Product
Table 142. BOYA LIFE Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. BOYA LIFE Revenue Proportion of Stem Cells by Product in 2024
Table 144. BOYA LIFE Revenue Proportion of Stem Cells by Application in 2024
Table 145. BOYA LIFE Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 146. BOYA LIFE Recent Developments
Table 147. Beike Biotechnology Corporation Information
Table 148. Beike Biotechnology Description and Business Overview
Table 149. Beike Biotechnology Stem Cells Product
Table 150. Beike Biotechnology Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Beike Biotechnology Revenue Proportion of Stem Cells by Product in 2024
Table 152. Beike Biotechnology Revenue Proportion of Stem Cells by Application in 2024
Table 153. Beike Biotechnology Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 154. Beike Biotechnology Recent Developments
Table 155. International Medical Corporation Information
Table 156. International Medical Description and Business Overview
Table 157. International Medical Stem Cells Product
Table 158. International Medical Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. International Medical Revenue Proportion of Stem Cells by Product in 2024
Table 160. International Medical Revenue Proportion of Stem Cells by Application in 2024
Table 161. International Medical Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 162. International Medical Recent Developments
Table 163. Global Cord Blood Corporation Corporation Information
Table 164. Global Cord Blood Corporation Description and Business Overview
Table 165. Global Cord Blood Corporation Stem Cells Product
Table 166. Global Cord Blood Corporation Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. Global Cord Blood Corporation Revenue Proportion of Stem Cells by Product in 2024
Table 168. Global Cord Blood Corporation Revenue Proportion of Stem Cells by Application in 2024
Table 169. Global Cord Blood Corporation Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 170. Global Cord Blood Corporation Recent Developments
Table 171. Beijing Health-Biotech Group Corporation Information
Table 172. Beijing Health-Biotech Group Description and Business Overview
Table 173. Beijing Health-Biotech Group Stem Cells Product
Table 174. Beijing Health-Biotech Group Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 175. Beijing Health-Biotech Group Revenue Proportion of Stem Cells by Product in 2024
Table 176. Beijing Health-Biotech Group Revenue Proportion of Stem Cells by Application in 2024
Table 177. Beijing Health-Biotech Group Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 178. Beijing Health-Biotech Group Recent Developments
Table 179. ABMD Corporation Information
Table 180. ABMD Description and Business Overview
Table 181. ABMD Stem Cells Product
Table 182. ABMD Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. ABMD Revenue Proportion of Stem Cells by Product in 2024
Table 184. ABMD Revenue Proportion of Stem Cells by Application in 2024
Table 185. ABMD Revenue Proportion of Stem Cells by Geographic Area in 2024
Table 186. ABMD Recent Developments
Table 187. North America Stem Cells Revenue by Country (2020-2025) & (US$ Million)
Table 188. North America Stem Cells Revenue by Country (2026-2031) & (US$ Million)
Table 189. North America Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 190. North America Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 191. Asia-Pacific Stem Cells Revenue by Region (2020-2025) & (US$ Million)
Table 192. Asia-Pacific Stem Cells Revenue by Region (2026-2031) & (US$ Million)
Table 193. Asia-Pacific Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 194. Asia-Pacific Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 195. Europe Stem Cells Revenue by Country (2020-2025) & (US$ Million)
Table 196. Europe Stem Cells Revenue by Country (2026-2031) & (US$ Million)
Table 197. Europe Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 198. Europe Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 199. Latin America Stem Cells Revenue by Country (2020-2025) & (US$ Million)
Table 200. Latin America Stem Cells Revenue by Country (2026-2031) & (US$ Million)
Table 201. Latin America Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 202. Latin America Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 203. Middle East and Africa Stem Cells Revenue by Country (2020-2025) & (US$ Million)
Table 204. Middle East and Africa Stem Cells Revenue by Country (2026-2031) & (US$ Million)
Table 205. Middle East and Africa Stem Cells Revenue by Type (2020-2025) & (US$ Million)
Table 206. Middle East and Africa Stem Cells Revenue by Application (2020-2025) & (US$ Million)
Table 207. Stem Cells Key Raw Materials, Industry Status and Trend
Table 208. Stem Cells Key Raw Materials and Upstream Suppliers
Table 209. Stem Cells Clients Status and Trend
Table 210. Stem Cells Typical Clients
Table 211. Stem Cells Distributors
Table 212. Stem Cells Market Trends
Table 213. Stem Cells Market Drivers
Table 214. Stem Cells Market Challenges
Table 215. Stem Cells Market Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Stem Cells Product Picture
Figure 2. Global Stem Cells Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Stem Cells Revenue Market Share by Type in 2024 & 2031
Figure 4. Stem Cell Storage Product Picture
Figure 5. Stem Cell Pharmaceutical and Treatment Product Picture
Figure 6. Global Stem Cells Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Stem Cells Revenue Market Share by Application in 2024 & 2031
Figure 8. Blood Disease
Figure 9. Cancer
Figure 10. Autoimmune Disease
Figure 11. Others
Figure 12. Stem Cells Report Years Considered
Figure 13. Global Stem Cells Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Stem Cells Market Size (2020-2031) & (US$ Million)
Figure 15. Global Stem Cells Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Stem Cells Revenue Market Share by Region (2020-2031)
Figure 17. Global Stem Cells Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Stem Cells Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Stem Cell Storage of Stem Cells Revenue Market Share by Application, 2024 VS 2031
Figure 20. Stem Cell Pharmaceutical and Treatment of Stem Cells Revenue Market Share by Application, 2024 VS 2031
Figure 21. Stem Cells Revenue Share by Company (2024)
Figure 22. Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Stem Cell Storage Revenue Proportion by Company in 2024
Figure 24. Stem Cell Pharmaceutical and Treatment Revenue Proportion by Company in 2024
Figure 25. North America Stem Cells Revenue 2020-2031 (US$ Million)
Figure 26. North America Stem Cells Revenue Market Share by Type (2020-2025)
Figure 27. North America Stem Cells Revenue Market Share by Application (2020-2025)
Figure 28. Asia-Pacific Stem Cells Revenue 2020-2031 (US$ Million)
Figure 29. Asia-Pacific Stem Cells Revenue Market Share by Region (2020-2031)
Figure 30. Asia-Pacific Stem Cells Revenue Market Share by Type (2020-2025)
Figure 31. Asia-Pacific Stem Cells Revenue Market Share by Application (2020-2025)
Figure 32. Europe Stem Cells Revenue Growth Rate 2020-2031 (US$ Million)
Figure 33. Europe Stem Cells Revenue Market Share by Country (2020-2031)
Figure 34. Europe Stem Cells Revenue Market Share by Type (2020-2025)
Figure 35. Europe Stem Cells Revenue Market Share by Application (2020-2025)
Figure 36. Latin America Stem Cells Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Latin America Stem Cells Revenue Market Share by Country (2020-2031)
Figure 38. Latin America Stem Cells Revenue Market Share by Type (2020-2025)
Figure 39. Latin America Stem Cells Revenue Market Share by Application (2020-2025)
Figure 40. Middle East and Africa Stem Cells Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Middle East and Africa Stem Cells Revenue Market Share by Country (2020-2031)
Figure 42. Middle East and Africa Stem Cells Revenue Market Share by Type (2020-2025)
Figure 43. Middle East and Africa Stem Cells Revenue Market Share by Application (2020-2025)
Figure 44. Stem Cells Supply Chain (Upstream and Downstream Market)
Figure 45. Global Production Market Share of Stem Cells Raw Materials by Region in 2024
Figure 46. Stem Cells Distribution Channels
Figure 47. Global Stem Cells Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 48. Global Stem Cells Percentage 2020-2031: Online Sales VS Offline Sales
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232